Get started
SSS

STAYBLE THERAPEUTICS AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

STABL chart


Full chart

Key stats


Market capitalization
‪22.95 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.640 SEK
Net income (FY)
‪−23.74 M‬ SEK
Revenue (FY)
0.00 SEK
Shares float
—
Beta (1Y)
0.32

About STAYBLE THERAPEUTICS AB


Sector
Health Technology
CEO
Andreas Gerward
Headquarters
Gothenburg
Website
stayble.se
Founded
2015
ISIN
SE0013513652
FIGI
BBG00RM5KZR5
Stayble Therapeutics AB engages in the development of pharmaceutical products. It develops an injectable treatment against chronic low back pain triggered by disc degeneration. The company was founded by Kjell Olmarker, Mattias Münnich, and Andreas Gerward in 2015 and is headquartered in Gothenburg, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

STABL news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of STABL is 0.525 SEK — it has decreased by −11.02% in the past 24 hours. Watch STAYBLE THERAPEUTICS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange STAYBLE THERAPEUTICS AB stocks are traded under the ticker STABL.
STABL stock has fallen by −25.53% compared to the previous week, the month change is a −17.32% fall, over the last year STAYBLE THERAPEUTICS AB has showed a 86.83% increase.
STABL reached its all-time high on May 25, 2020 with the price of 13.575 SEK, and its all-time low was 0.190 SEK and was reached on Apr 19, 2024. View more price dynamics on STABL chart.
See other stocks reaching their highest and lowest prices.
STABL stock is 20.19% volatile and has beta coefficient of 0.32. Track STAYBLE THERAPEUTICS AB stock price on the chart and check out the list of the most volatile stocks — is STAYBLE THERAPEUTICS AB there?
Today STAYBLE THERAPEUTICS AB has the market capitalization of ‪22.95 M‬, it has decreased by −12.59% over the last week.
Yes, you can track STAYBLE THERAPEUTICS AB financials in yearly and quarterly reports right on TradingView.
STABL net income for the last quarter is ‪−3.44 M‬ SEK, while the quarter before that showed ‪−3.63 M‬ SEK of net income which accounts for 5.48% change. Track more STAYBLE THERAPEUTICS AB financial stats to get the full picture.
No, STABL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, STABL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAYBLE THERAPEUTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAYBLE THERAPEUTICS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAYBLE THERAPEUTICS AB stock shows the sell signal. See more of STAYBLE THERAPEUTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.